Raymond James & Associates’s Exelon Corporation EXCU Stock Holding History

Raymond James & Associates’s Portfolio EXCU Stock Details EXCU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-8,099	Closed	-$400K	–	3505
2017 Q1	$400K	Sell	8,099 -3,206	-28%	-$158K	﹤0.01%	2527
2016 Q4	$547K	Sell	11,305 -2,504	-18%	-$117K	﹤0.01%	2283
2016 Q3	$645K	Buy	13,809 +6,309	+84%	+$308K	﹤0.01%	2120
2016 Q2	$370K	Sell	7,500 -15,500	-67%	-$744K	﹤0.01%	2277
2016 Q1	$1.13M	Hold	23,000	–	–	﹤0.01%	1618
2015 Q4	$931K	Hold	23,000	–	–	﹤0.01%	1672
2015 Q3	$1M	Hold	23,000	–	–	﹤0.01%	1594
2015 Q2	$1.04M	Buy	23,000 +2,000	+10%	+$97.1K	﹤0.01%	1718
2015 Q1	$1.02M	Buy	+21,000	New	+$1.07M	﹤0.01%	1643

Raymond James & Associates's EXCU Position: Q2 2017 in Review

Raymond James & Associates sold out of Exelon Corporation (EXCU) in Q2 2017, closing a stake of 8,099 shares — an estimated $400K sold.

Raymond James & Associates first reported a position in EXCU in Q1 2015 and held it in 9 quarters. The position peaked at $1.13M in Q1 2016. 0 funds tracked by Wall St. Rank hold EXCU as of Q2 2017.

Raymond James & Associates reported no remaining Exelon Corporation position as of Q2 2017 after selling out during the quarter.
Raymond James & Associates sold 8,099 Exelon Corporation shares in Q2 2017, an estimated $400K.
Raymond James & Associates first reported a position in Exelon Corporation in Q1 2015 and held it in 9 quarters.
Raymond James & Associates's Exelon Corporation position peaked at $1.13M in Q1 2016.
0 funds tracked by Wall St. Rank held Exelon Corporation as of Q2 2017.

Based on Raymond James & Associates's 13F filing for Q2 2017, filed 14 Aug 2017.